BusinessWire

FDA Commissioner Stephen Hahn to Headline MDIC’s 2020 Annual Public Forum

ARLINGTON, Va.--(BUSINESS WIRE)--#COVID19--The Medical Device Innovation Consortium (MDIC) announced today that FDA Commissioner Dr. Stephen Hahn is headlining the organization’s 2020 Annual Public Forum on June 18, 2020. The Annual Public Forum is MDIC’s premiere event where the medical device and diagnostics community convene to discuss current trends in regulatory science as well as highlight the development of innovative regulatory science tools and industry priorities. In light of the health safety recommendations for the DC Metro area, MDIC will deliver its forum as a digital series through the summer, in place of an in-person, one day event.



“The Forum highlights the important role and impact our public-private partnership has in leveraging resources across the ecosystem to find solutions to common high impact challenges for patient benefit,” said Pamela Goldberg, MDIC president and CEO. “I’m pleased that Commissioner Hahn has agreed to join me for a fireside chat and share his vision for FDA priorities especially during the current COVID-19 pandemic.”

The fireside chat will not only touch on the Commissioner’s role within the Agency, but also how FDA is handling COVID-19 and what it means for the industry. “Throughout COVID-19, we have seen the innovation that comes from the public and private sectors when the FDA partners with them. I look forward to our continued work with MDIC and talking about our shared vision and goals at the public forum,” said FDA Commissioner Stephen M. Hahn, M.D.

This year’s forum will include a number of industry experts as they share their vision and strategy for improving diagnostic testing and product development using novel regulatory science approaches, collecting real-world evidence for use in regulatory decision making, including patients as strategic partners in medical device development, and the implementation of value-based strategies to improve patient access to medical technologies.

The FDA Center for Devices and Radiological Health (CDRH) Townhall session will return this year, airing on June 25, 2020 and moderated by CVRx President and CEO and MDIC Board Chairman, Nadim Yared. Panelists will include Director of CDRH, Jeff Shuren, J.D., M.D., as well as other CDRH leaders as they discuss FDA’s strategic priorities and collaborations with MDIC. For additional information or to register for MDIC’s Annual Public Forum, visit apf.mdic.org.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives aim to improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit http://www.mdic.org.


Contacts

Leah Dergachev
ldergachev@mdic.org
+1 202.900.9099

BusinessWire

FDA Commissioner Stephen Hahn to Headline MDIC’s 2020 Annual Public Forum

ARLINGTON, Va.--(BUSINESS WIRE)--#COVID19--The Medical Device Innovation Consortium (MDIC) announced today that FDA Commissioner Dr. Stephen Hahn is headlining the organization’s 2020 Annual Public Forum on June 18, 2020. The Annual Public Forum is MDIC’s premiere event where the medical device and diagnostics community convene to discuss current trends in regulatory science as well as highlight the development of innovative regulatory science tools and industry priorities. In light of the health safety recommendations for the DC Metro area, MDIC will deliver its forum as a digital series through the summer, in place of an in-person, one day event.



“The Forum highlights the important role and impact our public-private partnership has in leveraging resources across the ecosystem to find solutions to common high impact challenges for patient benefit,” said Pamela Goldberg, MDIC president and CEO. “I’m pleased that Commissioner Hahn has agreed to join me for a fireside chat and share his vision for FDA priorities especially during the current COVID-19 pandemic.”

The fireside chat will not only touch on the Commissioner’s role within the Agency, but also how FDA is handling COVID-19 and what it means for the industry. “Throughout COVID-19, we have seen the innovation that comes from the public and private sectors when the FDA partners with them. I look forward to our continued work with MDIC and talking about our shared vision and goals at the public forum,” said FDA Commissioner Stephen M. Hahn, M.D.

This year’s forum will include a number of industry experts as they share their vision and strategy for improving diagnostic testing and product development using novel regulatory science approaches, collecting real-world evidence for use in regulatory decision making, including patients as strategic partners in medical device development, and the implementation of value-based strategies to improve patient access to medical technologies.

The FDA Center for Devices and Radiological Health (CDRH) Townhall session will return this year, airing on June 25, 2020 and moderated by CVRx President and CEO and MDIC Board Chairman, Nadim Yared. Panelists will include Director of CDRH, Jeff Shuren, J.D., M.D., as well as other CDRH leaders as they discuss FDA’s strategic priorities and collaborations with MDIC. For additional information or to register for MDIC’s Annual Public Forum, visit apf.mdic.org.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives aim to improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit http://www.mdic.org.


Contacts

Leah Dergachev
ldergachev@mdic.org
+1 202.900.9099